Lifordi Immunotherapeutics
Burlington
About Lifordi Immunotherapeutics
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $112.0M
- Last round: Series Unknown (Nov 2025)
- Website: lifordi.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/lifordi-immunotherapeutics-92493 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.